Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Pulmonary Hypertension

  Free Subscription


1 Aging (Albany NY)
1 Am J Cardiol
1 Am J Physiol Cell Physiol
2 Am J Physiol Heart Circ Physiol
1 Arch Bronconeumol (Engl Ed)
1 Biochim Biophys Acta Mol Basis Dis
4 Br J Pharmacol
1 Circulation
1 Clin Transplant
1 Curr Med Res Opin
1 ESC Heart Fail
1 Eur Heart J Case Rep
2 Eur J Pediatr
1 Eur Respir J
1 Hypertens Res
1 Indian J Pediatr
1 Int J Cardiovasc Imaging
1 J Card Fail
1 J Infect Dis
1 J Neonatal Perinatal Med
1 J Thorac Dis
1 Lancet Respir Med
2 Life Sci
1 Medicine (Baltimore)
1 Pediatr Cardiol
1 Pediatr Pulmonol
1 PLoS One
1 Pulm Circ
1 Respiration
1 Rofo
1 S D Med
1 Sci Rep
1 Thromb Res
1 Tuberc Respir Dis (Seoul)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aging (Albany NY)

  1. MIAO R, Dong X, Gong J, Li Y, et al
    Cell landscape atlas for patients with chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy constructed using single-cell RNA sequencing.
    Aging (Albany NY). 2021;13.
    PubMed         Abstract available

    Am J Cardiol

  2. WANG JK, Chiu SN, Lin MT, Chen CA, et al
    Transcatheter Closure of Atrial Septal Defect Associated with Pulmonary Artery Hypertension using Fenestrated Devices.
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00096.
    PubMed         Abstract available

    Am J Physiol Cell Physiol

  3. SUN H, Paudel O, Sham JSK
    Increased intracellular Cl(-) Concentrations in Pulmonary Arterial Myocytes Associated with Chronic Hypoxic Pulmonary Hypertension.
    Am J Physiol Cell Physiol. 2021 Jun 23. doi: 10.1152/ajpcell.00172.2021.
    PubMed         Abstract available

    Am J Physiol Heart Circ Physiol

  4. COLEBANK MJ, Qureshi MU, Rajagopal S, Krasuski RA, et al
    A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension.
    Am J Physiol Heart Circ Physiol. 2021 Jun 18. doi: 10.1152/ajpheart.00086.2021.
    PubMed         Abstract available

  5. FERGUSON BS, Wennersten SA, Demos-Davies KM, Rubino M, et al
    DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
    Am J Physiol Heart Circ Physiol. 2021 Jun 18. doi: 10.1152/ajpheart.00115.2021.
    PubMed         Abstract available

    Arch Bronconeumol (Engl Ed)

  6. PALOMEQUE A, Vollmer I, Fontana A, Lucena CM, et al
    Focal Mediastinitis and Pulmonary Arterial Thrombosis after EBUS-TBNA.
    Arch Bronconeumol (Engl Ed). 2021;57:73-74.

    Biochim Biophys Acta Mol Basis Dis

  7. LOPEZ-CRISOSTO C, Arias-Carrasco R, Sepulveda P, Garrido-Olivares L, et al
    Novel molecular insights and public omics data in pulmonary hypertension.
    Biochim Biophys Acta Mol Basis Dis. 2021 Jun 15:166200.
    PubMed         Abstract available

    Br J Pharmacol

  8. MAMAZHAKYPOV A, Viswanathan G, Lawrie A, Schermuly RT, et al
    The role of chemokines and chemokine receptors in pulmonary arterial hypertension.
    Br J Pharmacol. 2021;178:72-89.
    PubMed         Abstract available

  9. SOMMER N, Ghofrani HA, Pak O, Bonnet S, et al
    Current and future treatments of pulmonary arterial hypertension.
    Br J Pharmacol. 2021;178:6-30.
    PubMed         Abstract available

  10. ZHANG C, Lu W, Luo X, Liu S, et al
    Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats.
    Br J Pharmacol. 2021;178:217-235.
    PubMed         Abstract available

  11. HARBAUM L, Rhodes CJ, Otero-Nunez P, Wharton J, et al
    The application of 'omics' to pulmonary arterial hypertension.
    Br J Pharmacol. 2021;178:108-120.
    PubMed         Abstract available


  12. SATOH T, Wang L, Espinosa-Diez C, Wang B, et al
    Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Down Regulation of sGC and Contributes to Exercise-Induced Pulmonary Hypertension in HFpEF.
    Circulation. 2021 Jun 23. doi: 10.1161/CIRCULATIONAHA.121.053889.
    PubMed         Abstract available

    Clin Transplant

  13. KORBITZ PM, Gallagher JP, Samant H, Singh S, et al
    Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: Meta-analysis.
    Clin Transplant. 2020 Jun 2:e13995. doi: 10.1111/ctr.13995.
    PubMed         Abstract available

    Curr Med Res Opin

  14. KANWAR MK, Cole M, Gauthier-Loiselle M, Manceur AM, et al
    Development and validation of a claims-based model to identify patients at risk of chronic thromboembolic pulmonary hypertension following acute pulmonary embolism.
    Curr Med Res Opin. 2021 Jun 24:1-33. doi: 10.1080/03007995.2021.1947215.
    PubMed         Abstract available

    ESC Heart Fail

  15. NAGAMATSU Y, Goda A, Ito J, Takeuchi K, et al
    Novel diagnostic and therapeutic approaches to pulmonary hypertension due to the unilateral absence of a pulmonary artery.
    ESC Heart Fail. 2021 Jun 16. doi: 10.1002/ehf2.13459.
    PubMed         Abstract available

    Eur Heart J Case Rep

  16. BLASI FBM, Rota I, Graziadei G, Vicenzi M, et al
    The tailor-made treatment in a particular case of pulmonary hypertension in thalassaemia intermedia: a case report.
    Eur Heart J Case Rep. 2021;5:ytab193.
    PubMed         Abstract available

    Eur J Pediatr

  17. WU J, Lu Y, Zhao W, Shen J, et al
    Clinical characteristics and therapeutic outcomes of pulmonary arterial hypertension secondary to congenital portosystemic shunts.
    Eur J Pediatr. 2020 Oct 3. pii: 10.1007/s00431-020-03817.
    PubMed         Abstract available

  18. TAN Y, Wang S, Ren X, Zhang C, et al
    The prognostic implications of perioperative endogenous hydrogen sulfide and nitric oxide levels in children with congenital heart disease complicated by pulmonary arterial hypertension.
    Eur J Pediatr. 2021 Feb 8. pii: 10.1007/s00431-020-03897.
    PubMed         Abstract available

    Eur Respir J

  19. ABMAN SH, Mullen MP, Sleeper LA, Austin ED, et al
    Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry.
    Eur Respir J. 2021 Jun 17. pii: 13993003.03337-2020.
    PubMed         Abstract available

    Hypertens Res

  20. YANG Q, Zhang Z, Liao J, Zhang J, et al
    The causality between CFTR and pulmonary hypertension: insights from Mendelian randomization studies.
    Hypertens Res. 2021 Jun 21. pii: 10.1038/s41440-021-00680.

    Indian J Pediatr

  21. BETHOU A
    Utility of Nebulized Magnesium Sulfate Therapy for Persistent Pulmonary Hypertension of Newborn.
    Indian J Pediatr. 2021 Jun 23. pii: 10.1007/s12098-021-03851.

    Int J Cardiovasc Imaging

  22. VENKATESHVARAN A, Seidova N, Tureli HO, Kjellstrom B, et al
    Accuracy of echocardiographic estimates of pulmonary artery pressures in pulmonary hypertension: insights from the KARUM hemodynamic database.
    Int J Cardiovasc Imaging. 2021 Jun 19. pii: 10.1007/s10554-021-02315.
    PubMed         Abstract available

    J Card Fail

  23. BRENER MI, Hamid NB, Sunagawa K, Borlaug BA, et al
    Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action from the HELP Trial.
    J Card Fail. 2021 Jun 15. pii: S1071-9164(21)00215.

    J Infect Dis

  24. SCANLON KM, Chen L, Carbonetti NH
    Pertussis toxin promotes pulmonary hypertension in an infant mouse model of Bordetella pertussis infection.
    J Infect Dis. 2021 Jun 19. pii: 6305603. doi: 10.1093.
    PubMed         Abstract available

    J Neonatal Perinatal Med

  25. MILTON AD, Almazroue H, Jin Y, Zender G, et al
    DDAH1 SNP rs480414 that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia results in lower nitric oxide production in neonatal cord blood-derived lymphoblastoid cell lines.
    J Neonatal Perinatal Med. 2021 Jun 17. pii: NPM210710. doi: 10.3233/NPM-210710.
    PubMed         Abstract available

    J Thorac Dis

  26. KAINUMA S, Toda K, Miyagawa S, Yoshikawa Y, et al
    Detrimental effects of elevated transpulmonary gradient on outcomes following restrictive mitral annuloplasty in patients with pre-existing pulmonary hypertension.
    J Thorac Dis. 2021;13:2746-2757.
    PubMed         Abstract available

    Lancet Respir Med

  27. HOEPER MM, Al-Hiti H, Benza RL, Chang SA, et al
    Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
    Lancet Respir Med. 2021;9:573-584.
    PubMed         Abstract available

    Life Sci

  28. LIU J, Sun Y, Zhu B, Lin Y, et al
    Identification of a potentially novel LncRNA-miRNA-mRNA competing endogenous RNA network in pulmonary arterial hypertension via integrated bioinformatic analysis.
    Life Sci. 2021;277:119455.
    PubMed         Abstract available

  29. WANG F, Quan Q
    Anti-inflammatory role and mechanism of microRNA-92b-3p in the progression of hypoxic pulmonary hypertension.
    Life Sci. 2021 Jun 16:119725. doi: 10.1016/j.lfs.2021.119725.
    PubMed         Abstract available

    Medicine (Baltimore)

  30. BALDI BG, Fernandes CJCDS, Heiden GI, Freitas CSG, et al
    Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseases.
    Medicine (Baltimore). 2021;100:e26483.
    PubMed         Abstract available

    Pediatr Cardiol

  31. ZHAO H, Guo A, Wang M, Cai Z, et al
    The Influence of Bosentan on MicroRNA-27a/PPARgamma/ET-1 Signaling Pathway in Pulmonary Artery Hypertension.
    Pediatr Cardiol. 2021;42:1141-1148.
    PubMed         Abstract available

    Pediatr Pulmonol

  32. SHARMA C, Burns J, Kulkarni A, Cerise JE, et al
    Continuous and intermittent administration of intravenous sildenafil in critically ill infants with pulmonary hypertension.
    Pediatr Pulmonol. 2021 Jun 18. doi: 10.1002/ppul.25539.
    PubMed         Abstract available

    PLoS One

  33. MOHER ALSADY T, Kaireit TF, Behrendt L, Winther HB, et al
    Comparison of dual-energy computer tomography and dynamic contrast-enhanced MRI for evaluating lung perfusion defects in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2021;16:e0251740.
    PubMed         Abstract available

    Pulm Circ

  34. DUBROCK HM, Burger CD, Bartolome SD, Feldman JP, et al
    Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry.
    Pulm Circ. 2021;11:20458940211020913.
    PubMed         Abstract available


  35. BOUTOU AK, Panagiotidou E, Zacharias A, Stanopoulos I, et al
    Early Pulmonary Rehabilitation after Pulmonary Endarterectomy: Both Safe and Effective?
    Respiration. 2021;100:182-183.


  36. SCHUSSLER A, Richter M, Tello K, Steiner D, et al
    Evaluation of Diagnostic Accuracy and Radiation Exposure of Dual-Energy Computed Tomography (DECT) in the Course of Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
    Rofo. 2021 Jun 17. doi: 10.1055/a-1502-7541.
    PubMed         Abstract available

    S D Med

  37. JOHNSON K, VandenHull A, Remund T, Pohlson K, et al
    Short-term Cost Comparison of Systemic Heparin Therapy vs. Catheter Directed Thrombolysis for the Treatment of Massive and Submassive Pulmonary Embolism with Long-Term Chronic Pulmonary Hypertension Cost Model.
    S D Med. 2021;74:70-74.
    PubMed         Abstract available

    Sci Rep

  38. PRIYA S, Aggarwal T, Ward C, Bathla G, et al
    Radiomics side experiments and DAFIT approach in identifying pulmonary hypertension using Cardiac MRI derived radiomics based machine learning models.
    Sci Rep. 2021;11:12686.
    PubMed         Abstract available

    Thromb Res

  39. DZIKOWSKA-DIDUCH O, Kostrubiec M, Kurnicka K, Lichodziejewska B, et al
    "The post-pulmonary syndrome - results of echocardiographic driven follow up after acute pulmonary embolism".
    Thromb Res. 2019;186:30-35.
    PubMed         Abstract available

    Tuberc Respir Dis (Seoul)

  40. PARK JH, Na JO, Lee JS, Kim YH, et al
    2020 KSC/KATRD guideline for the diagnosis and treatment of pulmonary hypertension: Executive summary.
    Tuberc Respir Dis (Seoul). 2021 Jun 4. pii: trd.2021.0022.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.